RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS

Methods of treating disorders affecting the central nervous system (CNS) are disclosed. More particularly, methods of treating neurological disorders are disclosed which show therapeutic or prophylactic treatment of a mammalian CNS disorder by effecting local administration of an iRNA agent, followe...

Full description

Saved in:
Bibliographic Details
Main Authors STEWART, ROBERT, GREGORY, SAH, DINAH
Format Patent
LanguageEnglish
French
Published 21.02.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods of treating disorders affecting the central nervous system (CNS) are disclosed. More particularly, methods of treating neurological disorders are disclosed which show therapeutic or prophylactic treatment of a mammalian CNS disorder by effecting local administration of an iRNA agent, followed by retrograde transport of the iRNA agent away from the administration site and onto multiple regions within the CNS. This retrograde transport of iRNA results in an improved therapeutic involvement for the respective iRNA agent. La présente invention concerne des procédés de traitement de troubles qui affectent le système nerveux central (SNC). L'invention concerne plus particulièrement des procédés de traitement de troubles neurologiques qui permettent le traitement thérapeutique ou prophylactique d'un trouble du SNC mammalien grâce à l'administration locale d'un agent de type ARNi, suivie par le transport en sens rétrograde de l'agent de type ARNi dans des zones éloignées du site d'administration et dans de multiples régions du SNC. Ce transport en sens rétrograde de l'ARNi conduit à une meilleure implication thérapeutique de l'agent de type ARNi respectif.
Bibliography:Application Number: WO2007US17680